152 related articles for article (PubMed ID: 20446020)
1. 17beta-estradiol inhibits prostaglandin E2-induced COX-2 expressions and cell migration by suppressing Akt and ERK1/2 signaling pathways in human LoVo colon cancer cells.
Lai TY; Chen LM; Lin JY; Tzang BS; Lin JA; Tsai CH; Lin YM; Huang CY; Liu CJ; Hsu HH
Mol Cell Biochem; 2010 Sep; 342(1-2):63-70. PubMed ID: 20446020
[TBL] [Abstract][Full Text] [Related]
2. JNK suppression is essential for 17β-Estradiol inhibits prostaglandin E2-Induced uPA and MMP-9 expressions and cell migration in human LoVo colon cancer cells.
Hsu HH; Hu WS; Lin YM; Kuo WW; Chen LM; Chen WK; Hwang JM; Tsai FJ; Liu CJ; Huang CY
J Biomed Sci; 2011 Aug; 18(1):61. PubMed ID: 21859479
[TBL] [Abstract][Full Text] [Related]
3. p38α MAPK mediates 17β-estradiol inhibition of MMP-2 and -9 expression and cell migration in human lovo colon cancer cells.
Hsu HH; Liu CJ; Shen CY; Chen YJ; Chen LM; Kuo WH; Lin YM; Chen RJ; Tsai CH; Tsai FJ; Huang CY
J Cell Physiol; 2012 Nov; 227(11):3648-60. PubMed ID: 22377968
[TBL] [Abstract][Full Text] [Related]
4. Prostaglandin E2-Induced COX-2 Expressions via EP2 and EP4 Signaling Pathways in Human LoVo Colon Cancer Cells.
Hsu HH; Lin YM; Shen CY; Shibu MA; Li SY; Chang SH; Lin CC; Chen RJ; Viswanadha VP; Shih HN; Huang CY
Int J Mol Sci; 2017 May; 18(6):. PubMed ID: 28587064
[TBL] [Abstract][Full Text] [Related]
5. Suppression of IL-8-Src signalling axis by 17β-estradiol inhibits human mesenchymal stem cells-mediated gastric cancer invasion.
Liu CJ; Kuo FC; Wang CL; Kuo CH; Wang SS; Chen CY; Huang YB; Cheng KH; Yokoyama KK; Chen CL; Lu CY; Wu DC
J Cell Mol Med; 2016 May; 20(5):962-72. PubMed ID: 26945908
[TBL] [Abstract][Full Text] [Related]
6. Thymoquinone suppresses migration of LoVo human colon cancer cells by reducing prostaglandin E2 induced COX-2 activation.
Hsu HH; Chen MC; Day CH; Lin YM; Li SY; Tu CC; Padma VV; Shih HN; Kuo WW; Huang CY
World J Gastroenterol; 2017 Feb; 23(7):1171-1179. PubMed ID: 28275297
[TBL] [Abstract][Full Text] [Related]
7. Estradiol agonists inhibit human LoVo colorectal-cancer cell proliferation and migration through p53.
Hsu HH; Kuo WW; Ju DT; Yeh YL; Tu CC; Tsai YL; Shen CY; Chang SH; Chung LC; Huang CY
World J Gastroenterol; 2014 Nov; 20(44):16665-73. PubMed ID: 25469035
[TBL] [Abstract][Full Text] [Related]
8. PI3K/Akt and ERK1/2 signalling pathways are involved in endometrial cell migration induced by 17beta-estradiol and growth factors.
Gentilini D; Busacca M; Di Francesco S; Vignali M; Viganò P; Di Blasio AM
Mol Hum Reprod; 2007 May; 13(5):317-22. PubMed ID: 17350964
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of RGS4 expression by IL-1beta in colonic smooth muscle is enhanced by ERK1/2 and p38 MAPK and inhibited by the PI3K/Akt/GSK3beta pathway.
Hu W; Li F; Mahavadi S; Murthy KS
Am J Physiol Cell Physiol; 2009 Jun; 296(6):C1310-20. PubMed ID: 19369446
[TBL] [Abstract][Full Text] [Related]
10. Prostaglandin D(2) induces apoptosis of human osteoclasts through ERK1/2 and Akt signaling pathways.
Yue L; Haroun S; Parent JL; de Brum-Fernandes AJ
Bone; 2014 Mar; 60():112-21. PubMed ID: 24345643
[TBL] [Abstract][Full Text] [Related]
11. Resveratrol inhibits urban particulate matter-induced COX-2/PGE
Tsai MH; Hsu LF; Lee CW; Chiang YC; Lee MH; How JM; Wu CM; Huang CL; Lee IT
Int J Biochem Cell Biol; 2017 Jul; 88():113-123. PubMed ID: 28495310
[TBL] [Abstract][Full Text] [Related]
12. Prostaglandin E2 transactivates the colony-stimulating factor-1 receptor and synergizes with colony-stimulating factor-1 in the induction of macrophage migration via the mitogen-activated protein kinase ERK1/2.
Digiacomo G; Ziche M; Dello Sbarba P; Donnini S; Rovida E
FASEB J; 2015 Jun; 29(6):2545-54. PubMed ID: 25757564
[TBL] [Abstract][Full Text] [Related]
13. Potentiation of the antitumor effects of both selective cyclooxygenase-1 and cyclooxygenase-2 inhibitors in human hepatic cancer cells by inhibition of the MEK/ERK pathway.
Cusimano A; Foderà D; D'Alessandro N; Lampiasi N; Azzolina A; Montalto G; Cervello M
Cancer Biol Ther; 2007 Sep; 6(9):1461-8. PubMed ID: 18424914
[TBL] [Abstract][Full Text] [Related]
14. Cadmium Induces Migration of Colon Cancer Cells: Roles of Reactive Oxygen Species, P38 and Cyclooxygenase-2.
Naji S; Issa K; Eid A; Iratni R; Eid AH
Cell Physiol Biochem; 2019; 52(6):1517-1534. PubMed ID: 31120230
[TBL] [Abstract][Full Text] [Related]
15. Hypertonic environment elicits cyclooxygenase-2-driven prostaglandin E2 generation by colon cancer cells: role of cytosolic phospholipase A2-alpha and kinase signaling pathways.
Gentile LB; Piva B; Capizzani BC; Furlaneto LG; Moreira LS; Zamith-Miranda D; Diaz BL
Prostaglandins Leukot Essent Fatty Acids; 2010; 82(2-3):131-9. PubMed ID: 20004562
[TBL] [Abstract][Full Text] [Related]
16. Action of methyl-, propyl- and butylparaben on GPR30 gene and protein expression, cAMP levels and activation of ERK1/2 and PI3K/Akt signaling pathways in MCF-7 breast cancer cells and MCF-10A non-transformed breast epithelial cells.
Wróbel AM; Gregoraszczuk EŁ
Toxicol Lett; 2015 Oct; 238(2):110-6. PubMed ID: 26253279
[TBL] [Abstract][Full Text] [Related]
17. All-trans retinoic acid induces COX-2 and prostaglandin E2 synthesis in SH-SY5Y human neuroblastoma cells: involvement of retinoic acid receptors and extracellular-regulated kinase 1/2.
Alique M; Herrero JF; Lucio-Cazana FJ
J Neuroinflammation; 2007 Jan; 4():1. PubMed ID: 17204142
[TBL] [Abstract][Full Text] [Related]
18. Curcumin inhibits phorbol ester-induced up-regulation of cyclooxygenase-2 and matrix metalloproteinase-9 by blocking ERK1/2 phosphorylation and NF-kappaB transcriptional activity in MCF10A human breast epithelial cells.
Lee KW; Kim JH; Lee HJ; Surh YJ
Antioxid Redox Signal; 2005; 7(11-12):1612-20. PubMed ID: 16356124
[TBL] [Abstract][Full Text] [Related]
19. Sphingosine-1-phosphate induces COX-2 expression via PI3K/Akt and p42/p44 MAPK pathways in rat vascular smooth muscle cells.
Hsieh HL; Wu CB; Sun CC; Liao CH; Lau YT; Yang CM
J Cell Physiol; 2006 Jun; 207(3):757-66. PubMed ID: 16508949
[TBL] [Abstract][Full Text] [Related]
20. Serotonin activates MAP kinase and PI3K/Akt signaling pathways in prostate cancer cell lines.
Dizeyi N; Hedlund P; Bjartell A; Tinzl M; Austild-Taskén K; Abrahamsson PA
Urol Oncol; 2011; 29(4):436-45. PubMed ID: 19926313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
